PEPTONIC Medical AB (PMED.ST)

0.0086 -0.0004 (-4.44%) As of 02:30PM CEST. Market open.

PEPTONIC Medical AB

Gustavslundsvägen 143
Bromma 167 51
Sweden
46 8 53 02 01 10
https://www.peptonicmedical.se

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 28

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Albert Lindgren	Chief Financial Officer	N/A	N/A	N/A
Mr. Dan Markusson	Chief Operating Officer	N/A	N/A	N/A
Heli Kurjanen	CEO of Lune Group Oy	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

PEPTONIC medical AB (publ), a pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health. It offers VagiVital, a hormone-free treatment for symptoms related to vaginal atrophy, such as pain during intercourse, burning, itching, and dryness, as well as moisturizing and an oil-based intimate wash. The company also provides lifestyle consumer products under the Lunette brand. PEPTONIC medical AB (publ) was incorporated in 2009 and is headquartered in Bromma, Sweden.

Corporate governance

PEPTONIC Medical AB’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.